8X8 INC /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that 8X8 INC /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $79.34M | May 30, 2018 |
| FY2018 | Dec 31, 2017 | $75.58M | May 30, 2018 |
| FY2018 | Sep 30, 2017 | $72.48M | May 30, 2018 |
| FY2018 | Jun 30, 2017 | $69.10M | May 30, 2018 |
| FY2018 | Mar 31, 2017 | $66.49M | May 30, 2018 |
| FY2018 | Dec 31, 2016 | $63.68M | May 30, 2018 |
| FY2018 | Sep 30, 2016 | $63.18M | May 30, 2018 |
| FY2018 | Jun 30, 2016 | $60.04M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $57.33M | May 30, 2017 |
| FY2017 | Dec 31, 2015 | $53.17M | May 30, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $715.07M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $728.71M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $743.94M | May 22, 2025 |
| FY2022 | Mar 31, 2022 | $181.37M | May 27, 2022 |
| FY2022 | Dec 31, 2021 | $156.87M | May 27, 2022 |
| FY2022 | Sep 30, 2021 | $151.56M | May 27, 2022 |
| FY2022 | Jun 30, 2021 | $148.33M | May 27, 2022 |
| FY2022 | Mar 31, 2021 | $144.72M | May 27, 2022 |
| FY2022 | Dec 31, 2020 | $136.69M | May 27, 2022 |
| FY2022 | Sep 30, 2020 | $129.13M | May 27, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $296.50M | May 30, 2018 |
| FY2018 | Mar 31, 2017 | $253.39M | May 30, 2018 |
| FY2018 | Mar 31, 2016 | $209.34M | May 30, 2018 |
| FY2017 | Mar 31, 2015 | $162.41M | May 30, 2017 |
| FY2012 | Mar 31, 2013 | $107.61M | May 28, 2013 |
| FY2012 | Mar 31, 2012 | $85.80M | May 28, 2013 |
| FY2012 | Mar 31, 2011 | $70.16M | May 28, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $485.27M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $503.80M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $502.46M | May 22, 2025 |
| FY2022 | Mar 31, 2022 | $112.87M | May 27, 2022 |
| FY2022 | Dec 31, 2021 | $97.04M | May 27, 2022 |
| FY2022 | Sep 30, 2021 | $92.09M | May 27, 2022 |
| FY2022 | Jun 30, 2021 | $88.57M | May 27, 2022 |
| FY2022 | Mar 31, 2021 | $83.61M | May 27, 2022 |
| FY2022 | Dec 31, 2020 | $76.28M | May 27, 2022 |
| FY2022 | Sep 30, 2020 | $72.64M | May 27, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($27.21M) | May 22, 2025 |
| FY2025 | Mar 31, 2024 | ($67.59M) | May 22, 2025 |
| FY2025 | Mar 31, 2023 | ($73.14M) | May 22, 2025 |
| FY2022 | Mar 31, 2022 | ($45.58M) | May 27, 2022 |
| FY2022 | Dec 31, 2021 | ($43.57M) | May 27, 2022 |
| FY2022 | Sep 30, 2021 | ($42.32M) | May 27, 2022 |
| FY2022 | Jun 30, 2021 | ($43.91M) | May 27, 2022 |
| FY2022 | Mar 31, 2021 | ($45.03M) | May 27, 2022 |
| FY2022 | Dec 31, 2020 | ($40.23M) | May 27, 2022 |
| FY2022 | Sep 30, 2020 | ($38.41M) | May 27, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $15.19M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | ($27.60M) | May 22, 2025 |
| FY2025 | Mar 31, 2023 | ($66.29M) | May 22, 2025 |
| FY2022 | Mar 31, 2022 | ($40.54M) | May 27, 2022 |
| FY2022 | Dec 31, 2021 | ($37.62M) | May 27, 2022 |
| FY2022 | Sep 30, 2021 | ($37.16M) | May 27, 2022 |
| FY2022 | Jun 30, 2021 | ($38.83M) | May 27, 2022 |
| FY2022 | Mar 31, 2021 | ($40.04M) | May 27, 2022 |
| FY2022 | Dec 31, 2020 | ($35.26M) | May 27, 2022 |
| FY2022 | Sep 30, 2020 | ($33.10M) | May 27, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $123.21M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $136.22M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $142.49M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $112.39M | May 21, 2024 |
| FY2023 | Mar 31, 2021 | $92.03M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $77.79M | May 27, 2022 |
| FY2019 | Mar 31, 2019 | $18.06M | May 21, 2019 |
| FY2019 | Dec 31, 2018 | $16.89M | May 21, 2019 |
| FY2019 | Sep 30, 2018 | $14.06M | May 21, 2019 |
| FY2019 | Jun 30, 2018 | $13.05M | May 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $63.55M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $78.99M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $48.79M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $34.68M | May 21, 2024 |
| FY2023 | Mar 31, 2021 | ($14.07M) | May 25, 2023 |
| FY2022 | Mar 31, 2020 | ($93.91M) | May 27, 2022 |
| FY2021 | Mar 31, 2019 | ($14.87M) | May 17, 2021 |
| FY2020 | Mar 31, 2018 | $22.04M | May 19, 2020 |
| FY2019 | Mar 31, 2017 | $28.48M | May 21, 2019 |
| FY2013 | Mar 31, 2014 | $14.92M | May 27, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.40M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $2.65M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $2.99M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $4.14M | May 21, 2024 |
| FY2023 | Mar 31, 2021 | $6.43M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $35.83M | May 27, 2022 |
| FY2021 | Mar 31, 2019 | $9.10M | May 17, 2021 |
| FY2020 | Mar 31, 2018 | $9.18M | May 19, 2020 |
| FY2019 | Mar 31, 2017 | $8.85M | May 21, 2019 |
| FY2018 | Mar 31, 2016 | $4.89M | May 30, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $683.18M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $755.98M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | $841.81M | May 21, 2024 |
| FY2023 | Mar 31, 2022 | $910.27M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $678.41M | May 27, 2022 |
| FY2021 | Mar 31, 2020 | $700.64M | May 17, 2021 |
| FY2020 | Mar 31, 2019 | $546.36M | May 19, 2020 |
| FY2019 | Mar 31, 2018 | $277.21M | May 21, 2019 |
| FY2018 | Mar 31, 2017 | $333.86M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $313.45M | May 30, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $560.97M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $654.02M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | $741.90M | May 21, 2024 |
| FY2023 | Mar 31, 2022 | $727.90M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $517.91M | May 27, 2022 |
| FY2021 | Mar 31, 2020 | $509.91M | May 17, 2021 |
| FY2020 | Mar 31, 2019 | $296.97M | May 19, 2020 |
| FY2019 | Mar 31, 2018 | $58.44M | May 21, 2019 |
| FY2018 | Mar 31, 2017 | $45.25M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $38.15M | May 30, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $122.20M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $101.96M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $99.91M | May 22, 2025 |
| FY2025 | Mar 31, 2022 | $182.37M | May 22, 2025 |
| FY2024 | Mar 31, 2021 | $160.50M | May 21, 2024 |
| FY2023 | Mar 31, 2020 | $190.73M | May 25, 2023 |
| FY2022 | Mar 31, 2019 | $249.39M | May 27, 2022 |
| FY2021 | Mar 31, 2018 | $218.77M | May 17, 2021 |
| FY2020 | Mar 31, 2017 | $288.60M | May 19, 2020 |
| FY2019 | Mar 31, 2016 | $275.31M | May 21, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $271.53M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $266.57M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $266.86M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $266.87M | May 21, 2024 |
| FY2023 | Mar 31, 2021 | $131.52M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $128.30M | May 27, 2022 |
| FY2021 | Mar 31, 2019 | $39.69M | May 17, 2021 |
| FY2020 | Mar 31, 2018 | $40.05M | May 19, 2020 |
| FY2019 | Mar 31, 2017 | $46.14M | May 21, 2019 |
| FY2018 | Mar 31, 2016 | $47.42M | May 30, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($887.72M) | May 22, 2025 |
| FY2025 | Mar 31, 2024 | ($860.51M) | May 22, 2025 |
| FY2024 | Mar 31, 2023 | ($792.92M) | May 21, 2024 |
| FY2023 | Mar 31, 2022 | ($766.44M) | May 25, 2023 |
| FY2022 | Mar 31, 2021 | ($591.06M) | May 27, 2022 |
| FY2021 | Mar 31, 2020 | ($422.67M) | May 17, 2021 |
| FY2020 | Mar 31, 2019 | ($250.30M) | May 19, 2020 |
| FY2019 | Apr 1, 2018 | ($161.56M) | May 21, 2019 |
| FY2019 | Mar 31, 2018 | ($201.46M) | May 21, 2019 |
| FY2018 | Mar 31, 2017 | ($114.61M) | May 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $88.05M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $116.26M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $111.40M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $91.21M | May 21, 2024 |
| FY2023 | Mar 31, 2021 | $112.53M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $137.39M | May 27, 2022 |
| FY2021 | Mar 31, 2019 | $276.58M | May 17, 2021 |
| FY2020 | Mar 31, 2018 | $31.70M | May 19, 2020 |
| FY2018 | Mar 31, 2017 | $41.03M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $33.58M | May 30, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $349.96M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $409.69M | May 22, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | May 22, 2025 |
| FY2025 | Mar 31, 2024 | 0 | May 22, 2025 |
| FY2025 | Mar 31, 2023 | 0 | May 22, 2025 |
| FY2022 | Mar 31, 2022 | 0 | May 27, 2022 |
| FY2022 | Dec 31, 2021 | 0 | May 27, 2022 |
| FY2022 | Sep 30, 2021 | 0 | May 27, 2022 |
| FY2022 | Jun 30, 2021 | 0 | May 27, 2022 |
| FY2022 | Mar 31, 2021 | 0 | May 27, 2022 |
| FY2022 | Dec 31, 2020 | 0 | May 27, 2022 |
| FY2022 | Sep 30, 2020 | 0 | May 27, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | May 22, 2025 |
| FY2025 | Mar 31, 2024 | 0 | May 22, 2025 |
| FY2025 | Mar 31, 2023 | 0 | May 22, 2025 |
| FY2022 | Mar 31, 2022 | 0 | May 27, 2022 |
| FY2022 | Dec 31, 2021 | 0 | May 27, 2022 |
| FY2022 | Sep 30, 2021 | 0 | May 27, 2022 |
| FY2022 | Jun 30, 2021 | 0 | May 27, 2022 |
| FY2022 | Mar 31, 2021 | 0 | May 27, 2022 |
| FY2022 | Dec 31, 2020 | 0 | May 27, 2022 |
| FY2022 | Sep 30, 2020 | 0 | May 27, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 134.36M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | 125.19M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | 114.66M | May 21, 2024 |
| FY2023 | Mar 31, 2022 | 117.86M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | 109.13M | May 27, 2022 |
| FY2021 | Mar 31, 2020 | 103.18M | May 17, 2021 |
| FY2020 | Mar 31, 2019 | 96.12M | May 19, 2020 |
| FY2019 | Mar 31, 2018 | 92.85M | May 21, 2019 |
| FY2018 | Mar 31, 2017 | 91.50M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | 89.21M | May 30, 2017 |